Medicam Minoxidil Tablets (Minoxidil)
Minoxidil 5mg
Tablet · Prescription medication
Medica Korea Co., Ltd.
MFDS item code 202105435 · Notified 2021.07.19
This product's status changed to Approval withdrawn on 2024.01.03. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of refractory hypertension and hypertension with symptoms or target-organ damage
This medication is used to treat hypertension caused by secondary causes or target organ damage, and refractory hypertension that does not respond to a diuretic and two types of antihypertensive agents.
Adults (12 years and older): The initial dose is 5㎎ of minoxidil administered orally once daily, and the maintenance dose is 10-40㎎ per day administered in 1-several divided doses. Up to 100㎎ per day may be administered. Dosing frequency: During treatment with this drug, the magnitude of fluctuations in arterial blood pressure over the course of a day is proportional to the reduction in blood pressure. If the decrease in supine diastolic blood pressure is less than 30mmHg, the drug may be administered once daily; if the decrease is 30mmHg or greater, administer the daily dose in 2 divided doses. Dose adjustment: The dose should be determined carefully according to the patient's response. When adjusting the dose, allow an interval of at least 3 days, as an adequate response to a dose may take 3 days or longer to appear. If more rapid treatment of hypertension is required, the dose may be adjusted every 6 hours while carefully monitoring the patient. Concomitant administration 1) Diuretics: This drug is administered concomitantly with a diuretic in patients who rely on renal function to maintain salt and water balance. It has been administered concomitantly with the following diuretics: ① Hydrochlorothiazide (50㎎ per dose, 2 times daily) or another thiazide diuretic (an equivalent effective dose) ② Chlorthalidone (50-100㎎ per dose, once daily) ③ Furosemide (40㎎ per dose, 2 times daily) If excessive salt and water retention causes a weight gain of approximately 1.8㎏ or more, the diuretic should be changed to furosemide; if the patient is already receiving furosemide, increase the dose as needed. 2) β-blockers or other sympatholytic agents: During treatment with this drug, administer a β-blocker in divided doses equivalent to 80-160㎎ of propranolol per day. If β-blockers are contraindicated, methyldopa (250-750㎎ per dose, 2 times daily) may be administered instead. Because methyldopa takes time to exert its effect, administer it at least 24 hours before starting this drug. Sympatholytic agents may not completely prevent the increase in heart rate caused by this drug, but can generally prevent tachycardia. Patients receiving a β-blocker before starting this drug typically have bradycardia; however, the heart rate is expected to increase to normal after this drug is administered. When this drug is administered concomitantly with a β-blocker or another sympatholytic agent, their opposing effects on the heart offset each other, resulting in little change in heart rate. The dose may be adjusted appropriately according to age and symptoms.
Pediatric patients (12 years or younger): The initial dose is 0.2㎎ per ㎏ of body weight once daily. The dose may be increased by 50-100% until blood pressure is optimally controlled. The maintenance dose is 0.25㎎-1.0㎎ per ㎏ of body weight daily. A maximum of 50㎎ may be administered daily.
This medication should not be used in certain patients. For example, patients with pheochromocytoma may experience a dangerous increase in catecholamine secretion from the tumor due to the blood pressure-lowering effects of this medication. Additionally, it should not be taken by patients with pulmonary hypertension due to mitral stenosis, patients who have had an acute myocardial infarction, or those who are hypersensitive to this medication. Patients with chronic congestive heart failure, severe renal failure, and angina should use this medication cautiously, as they may be more sensitive to its effects or side effects. One of the most common side effects of this medication is hypertrichosis, which can occur in about 80% of patients, leading to increased body hair or darkening of hair. This usually starts within 3 to 6 weeks after administration and can spread to other areas of the face and body. Stopping the medication halts new hair growth, but it may take 1 to 6 months to return to the original state. Additionally, skin rashes or blisters may occur, and in severe cases, serious allergic reactions such as Stevens-Johnson syndrome may arise. In the blood, reductions in platelet or white blood cell counts may occur, and hematocrit, hemoglobin, and red blood cell levels may temporarily decrease. Liver function tests may also show changes. Electrocardiograms often show changes in the shape and size of T waves, but these changes generally resolve with continued treatment and do not cause significant issues with heart function. Rarely, pericardial effusion may occur, particularly in patients with poor renal function. In such cases, echocardiography may be required, and discontinuation of the medication or additional treatment may be necessary. Other reported side effects include weight gain, peripheral vascular edema, increased heart rate, gastrointestinal disturbances, rash, breast pain, gynecomastia, antinuclear antibodies (ANA), intermittent claudication, frequent menstruation, peripheral vascular edema, increased heart rate, and temporary elevations in creatinine and BUN.
Hair growth, thickening, pigmentation increase, exudative rash, vesicular lesions, mucocutaneous syndrome, thrombocytopenia, leukopenia, decreased hematocrit, decreased hemoglobin, decreased red blood cells, increased ALP, changes in the direction and amplitude of the ECG T wave, pericardial effusion, cyanosis, peripheral vascular edema, increased heart rate, elevated creatinine, increased BUN, gastrointestinal disorders, rash, mastalgia, gynecomastia, hemolytic anemia, pulmonary infiltration, increased antinuclear antibodies, headache, intermittent claudication, frequent menstruation, nausea, vomiting
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to protect it from air and moisture. It is best to keep it at room temperature between 1 and 30 degrees Celsius, as this will help maintain its efficacy and safety.
White round tablets
30 tablets/bottle, 100 tablets/bottle, 300 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Minoxidil 5mg
Tablet · Prescription medication
Medica Korea Co., Ltd.

Minoxidil 5mg
Tablet · Prescription medication
Hyundai Pharmaceutical Co., Ltd.
Minoxidil 3g
OTC medication
Hyundai Pharmaceutical Co., Ltd.
Minoxidil 5g
OTC medication
Hyundai Pharmaceutical Co., Ltd.
Minoxidil 5g
OTC medication
Hanmi Pharmaceutical Co., Ltd.
Minoxidil 5g
Solution · OTC medication
JW Pharmaceutical Corp.
Minoxidil 3g
Solution · OTC medication
Haitai HTB Co., Ltd.
Minoxidil 5g
Solution · OTC medication
Ilhwa Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.